{"id":236541,"date":"2026-09-09T11:20:59","date_gmt":"2026-09-09T05:50:59","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=236541"},"modified":"2026-09-09T11:20:59","modified_gmt":"2026-09-09T05:50:59","slug":"bal-pharma-vs-nifty-50-share-price-performance","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/bal-pharma-vs-nifty-50-share-price-performance\/","title":{"rendered":"Bal Pharma vs Nifty 50: Share Price Performance Compared"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>Bal Pharma share price Rs 109.00 on NSE. Bal Pharma vs Nifty 50 over 1 year: +23.12% vs -4.61%. 52-week high Rs 109.79, low Rs 60.00.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E79;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">Bal Pharma vs Nifty 50 shows Bal Pharma ahead of the benchmark on a one-year view, gaining +23.12% against the Nifty 50&#8217;s -4.61%. Over the longer term the index has pulled ahead, a reminder that short-term outperformance does not always hold up over multi-year horizons. Investors comparing the two should also weigh Bal Pharma&#8217;s trading liquidity, valuation and sector context rather than relying on returns alone.<\/p>\n<\/p><\/div>\n<p>Bal Pharma vs Nifty 50 is a comparison that looks different depending on the time frame chosen. Bal Pharma trades on the NSE under the symbol BALPHARMA, and its 1M return of +23.74% compares with the Nifty 50&#8217;s -3.66% over the same period.<\/p>\n<p>The Bal Pharma vs Nifty 50 comparison matters because Bal Pharma is a single stock exposed to its own sector and company-specific developments, while the Nifty 50 spreads risk across 50 large companies. This article lines up Bal Pharma share price performance against the Nifty 50 across 1 month, 3 months, 6 months, 1 year, 3 years, 5 years, using NSE closing data.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=balpharma-vs-nifty50\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/bal-pharma-vs-nifty-50-share-price-performance\/#Bal_Pharma_vs_Nifty_50_Performance_at_a_Glance\" title=\"Bal Pharma vs Nifty 50: Performance at a Glance\">Bal Pharma vs Nifty 50: Performance at a Glance<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/bal-pharma-vs-nifty-50-share-price-performance\/#Why_the_Bal_Pharma_vs_Nifty_50_Gap_Exists\" title=\"Why the Bal Pharma vs Nifty 50 Gap Exists\">Why the Bal Pharma vs Nifty 50 Gap Exists<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/bal-pharma-vs-nifty-50-share-price-performance\/#Bal_Pharma_vs_Nifty_50_Has_Bal_Pharma_Beaten_the_Benchmark\" title=\"Bal Pharma vs Nifty 50: Has Bal Pharma Beaten the Benchmark?\">Bal Pharma vs Nifty 50: Has Bal Pharma Beaten the Benchmark?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/bal-pharma-vs-nifty-50-share-price-performance\/#Risks_of_the_Bal_Pharma_vs_Nifty_50_Comparison\" title=\"Risks of the Bal Pharma vs Nifty 50 Comparison\">Risks of the Bal Pharma vs Nifty 50 Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/bal-pharma-vs-nifty-50-share-price-performance\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/bal-pharma-vs-nifty-50-share-price-performance\/#Has_Bal_Pharma_outperformed_the_Nifty_50_in_the_last_year\" title=\"Has Bal Pharma outperformed the Nifty 50 in the last year?\">Has Bal Pharma outperformed the Nifty 50 in the last year?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/bal-pharma-vs-nifty-50-share-price-performance\/#How_does_Bal_Pharma_vs_Nifty_50_look_over_5_years\" title=\"How does Bal Pharma vs Nifty 50 look over 5 years?\">How does Bal Pharma vs Nifty 50 look over 5 years?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/bal-pharma-vs-nifty-50-share-price-performance\/#What_is_the_Bal_Pharma_share_price_today_compared_to_Nifty_50\" title=\"What is the Bal Pharma share price today compared to Nifty 50?\">What is the Bal Pharma share price today compared to Nifty 50?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/bal-pharma-vs-nifty-50-share-price-performance\/#What_is_the_52-week_high_and_low_of_Bal_Pharma\" title=\"What is the 52-week high and low of Bal Pharma?\">What is the 52-week high and low of Bal Pharma?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/bal-pharma-vs-nifty-50-share-price-performance\/#Why_does_Bal_Pharma_show_bigger_price_swings_than_the_Nifty_50\" title=\"Why does Bal Pharma show bigger price swings than the Nifty 50?\">Why does Bal Pharma show bigger price swings than the Nifty 50?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/bal-pharma-vs-nifty-50-share-price-performance\/#Is_Bal_Pharma_a_good_long-term_investment_compared_to_a_Nifty_50_index_fund\" title=\"Is Bal Pharma a good long-term investment compared to a Nifty 50 index fund?\">Is Bal Pharma a good long-term investment compared to a Nifty 50 index fund?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Bal_Pharma_vs_Nifty_50_Performance_at_a_Glance\"><\/span><strong>Bal Pharma vs Nifty 50: Performance at a Glance<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The table below sets out Bal Pharma vs Nifty 50 performance across the available time frames, measured from NSE closing prices up to 9 September 2026.<\/p>\n<table border=\"1\" cellpadding=\"6\" cellspacing=\"0\" style=\"border-collapse:collapse;width:100%;\">\n<thead>\n<tr>\n<th>Time Frame<\/th>\n<th>Bal Pharma Return<\/th>\n<th>Nifty 50 Return<\/th>\n<th>Difference<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1 Month<\/td>\n<td>+23.74%<\/td>\n<td>-3.66%<\/td>\n<td>+27.4% pp<\/td>\n<\/tr>\n<tr>\n<td>3 Months<\/td>\n<td>+26.89%<\/td>\n<td>+0.46%<\/td>\n<td>+26.43% pp<\/td>\n<\/tr>\n<tr>\n<td>6 Months<\/td>\n<td>+45.88%<\/td>\n<td>-5.53%<\/td>\n<td>+51.41% pp<\/td>\n<\/tr>\n<tr>\n<td>1 Year<\/td>\n<td>+23.12%<\/td>\n<td>-4.61%<\/td>\n<td>+27.73% pp<\/td>\n<\/tr>\n<tr>\n<td>3 Years<\/td>\n<td>+12.6%<\/td>\n<td>+20.86%<\/td>\n<td>-8.26% pp<\/td>\n<\/tr>\n<tr>\n<td>5 Years<\/td>\n<td>+11.74% (<a href=\"https:\/\/univest.in\/stocks\/balpharma\/bal-pharma-ltd-share-price-today\">Bal Pharma<\/a>)<\/td>\n<td>+35.35% (<a href=\"https:\/\/univest.in\/indices\/nifty-50\/nifty-50-share-price-today\">Nifty 50<\/a>)<\/td>\n<td>-23.61% pp<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>On the Bal Pharma vs Nifty 50 scorecard, Bal Pharma has stayed ahead of the index over the most recent one-year window. Over the longer term the index has pulled ahead, a reminder that short-term outperformance does not always hold up over multi-year horizons.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Check the Univest Screener for live Bal Pharma and Nifty 50 data<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_the_Bal_Pharma_vs_Nifty_50_Gap_Exists\"><\/span><strong>Why the Bal Pharma vs Nifty 50 Gap Exists<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Bal Pharma&#8217;s stock can move quite differently from the Nifty 50 because it carries concentrated exposure to its own sector and business cycle, unlike the index which blends 50 companies across banking, IT, energy and consumer sectors. This is the main driver of the gap seen in the Bal Pharma vs Nifty 50 return table above.<\/p>\n<p>A second factor behind the Bal Pharma vs Nifty 50 divergence is valuation and trading liquidity. Company-specific news, quarterly results and sector sentiment can move Bal Pharma&#8217;s price sharply in either direction over short periods, while the Nifty 50&#8217;s return reflects the blended earnings trajectory of its constituents and is far less exposed to any single stock&#8217;s swings.<\/p>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Bal Pharma and Nifty 50 live on the go.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Bal_Pharma_vs_Nifty_50_Has_Bal_Pharma_Beaten_the_Benchmark\"><\/span><strong>Bal Pharma vs Nifty 50: Has Bal Pharma Beaten the Benchmark?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Bal Pharma has beaten the Nifty 50 over the past year, gaining +23.12% against the index&#8217;s -4.61% over the same period.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Risks_of_the_Bal_Pharma_vs_Nifty_50_Comparison\"><\/span><strong>Risks of the Bal Pharma vs Nifty 50 Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Reading too much into a Bal Pharma vs Nifty 50 comparison has real limitations that investors should weigh before drawing conclusions. Bal Pharma carries concentrated business and sector risk that a diversified index does not, and its trading volumes and price swings can differ meaningfully from the Nifty 50&#8217;s more liquid, blended profile. A stock&#8217;s 52-week range of Rs 60.00 to Rs 109.79 also shows the kind of volatility that a single-stock investment carries relative to a broad index.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Bal Pharma vs Nifty 50 highlights how a single stock&#8217;s return path can differ from a diversified benchmark over different time horizons. Investors weighing the Bal Pharma vs Nifty 50 record should factor in Bal Pharma&#8217;s volatility, liquidity and sector concentration alongside its return history, and consult a SEBI-registered advisor before making an allocation decision.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/p><\/div>\n<h3><span class=\"ez-toc-section\" id=\"Has_Bal_Pharma_outperformed_the_Nifty_50_in_the_last_year\"><\/span><strong>Has Bal Pharma outperformed the Nifty 50 in the last year?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Yes. Bal Pharma gained +23.12% over the past year while the Nifty 50 returned -4.61% over the same period, based on NSE closing prices to 9 September 2026.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Bal_Pharma_vs_Nifty_50_look_over_5_years\"><\/span><strong>How does Bal Pharma vs Nifty 50 look over 5 years?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Over five years Bal Pharma has returned +11.74% compared with the Nifty 50&#8217;s +35.35%, so in the Bal Pharma vs Nifty 50 comparison the index has been ahead over this longer horizon.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Bal_Pharma_share_price_today_compared_to_Nifty_50\"><\/span><strong>What is the Bal Pharma share price today compared to Nifty 50?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Bal Pharma share price stood at Rs 109.00 on NSE, while the Nifty 50 traded at 23,490.45 based on the same closing data window.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_52-week_high_and_low_of_Bal_Pharma\"><\/span><strong>What is the 52-week high and low of Bal Pharma?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Bal Pharma&#8217;s 52-week high is Rs 109.79 and its 52-week low is Rs 60.00, based on NSE data.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_does_Bal_Pharma_show_bigger_price_swings_than_the_Nifty_50\"><\/span><strong>Why does Bal Pharma show bigger price swings than the Nifty 50?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Bal Pharma carries concentrated exposure to its own sector and business cycle, while the Nifty 50 spreads risk across 50 large companies, so company-specific news moves Bal Pharma&#8217;s price more sharply than the diversified index, a key reason the Bal Pharma vs Nifty 50 return gap varies across time frames.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Bal_Pharma_a_good_long-term_investment_compared_to_a_Nifty_50_index_fund\"><\/span><strong>Is Bal Pharma a good long-term investment compared to a Nifty 50 index fund?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Bal Pharma&#8217;s suitability depends on an investor&#8217;s risk appetite, since single-stock exposure carries higher concentration risk than a diversified Nifty 50 index fund; long-term investors should weigh the Bal Pharma vs Nifty 50 return history alongside the company&#8217;s fundamentals and consult a SEBI-registered advisor.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A data-led look at how Bal Pharma share price has performed against the Nifty 50 across multiple time frames.<\/p>\n","protected":false},"author":29,"featured_media":236540,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[24],"tags":[],"class_list":["post-236541","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["236540"],"rank_math_title":["Bal Pharma vs Nifty 50: Share Price Performance Compared"],"rank_math_description":["See how Bal Pharma share price has performed against the Nifty 50 across multiple time frames, with returns compared side by side using NSE closing data."],"rank_math_focus_keyword":["Bal Pharma vs Nifty 50"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/09\/bal-pharma-vs-nifty-50-share-price-performance.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/236541","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=236541"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/236541\/revisions"}],"predecessor-version":[{"id":236542,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/236541\/revisions\/236542"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/236540"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=236541"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=236541"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=236541"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}